Kawasaki, Ryohei
Sakata, Asuka
Tatsumi, Kohei
Mitani, Seiji
Takeda, Maiko
Kasuda, Shogo
Matsumoto, Naoki
Harada, Suguru
Soeda, Tetsuhiro
Nishida, Yukiko
Yoshimura, Yasushi
Shima, Midori
Funding for this research was provided by:
Chugai Pharmaceutical
Article History
Received: 29 September 2023
Accepted: 18 October 2024
First Online: 29 November 2024
Declarations
:
: RK, AS, KT, NM, SH, TS, YN, and MS: members of Medical Biology of Thrombosis and Hemostasis established by Nara Medical University and Chugai Pharmaceutical Co., Ltd.RK, NM, SH, TS, YN, and YY: employees of Chugai Pharmaceutical Co., Ltd.RK, NM, SH, and YY: stock ownership of Chugai Pharmaceutical Co., Ltd.TS, YN, YY, and MS: Patents for inventions relating to products of Chugai Pharmaceutical Co., Ltd.AS: speaker’s bureau from CSL Behring.KT: grants or research support from Japan Blood Products Organization, The Mother and Child Health Foundation and Novo Nordisk Pharma.SM, MT, and SK: no competing interest.MS: representative of Medical Biology of Thrombosis and Hemostasis collaborative research laboratory.; research support from Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. and CSL Behring.; honoraria or consultation fees from Chugai Pharmaceutical Co., Ltd.; speaker’s bureau from Chugai Pharmaceutical Co., Ltd., CSL Behring, Sanofi, Bayer, Novo Nordisk Pharma, Takeda Pharmaceutical Co., Ltd., Pfizer and Fujimoto Seiyaku Corp. RK, NM, SH, TS, YN, and YY: employees of Chugai Pharmaceutical Co., Ltd. RK, NM, SH, and YY: stock ownership of Chugai Pharmaceutical Co., Ltd. TS, YN, YY, and MS: Patents for inventions relating to products of Chugai Pharmaceutical Co., Ltd. AS: speaker’s bureau from CSL Behring. KT: grants or research support from Japan Blood Products Organization, The Mother and Child Health Foundation and Novo Nordisk Pharma. SM, MT, and SK: no competing interest. MS: representative of Medical Biology of Thrombosis and Hemostasis collaborative research laboratory.; research support from Chugai Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd. and CSL Behring.; honoraria or consultation fees from Chugai Pharmaceutical Co., Ltd.; speaker’s bureau from Chugai Pharmaceutical Co., Ltd., CSL Behring, Sanofi, Bayer, Novo Nordisk Pharma, Takeda Pharmaceutical Co., Ltd., Pfizer and Fujimoto Seiyaku Corp.